CureDM Report issue

For profit Phase 1
Founded: Wilmington DE United States (2004)
Status: Acquired by Boston Therapeutics (2018)

Organization Overview

First Clinical Trial
2012
NCT01638611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree